Improving Survival in Patients with Pulmonary Arterial Hypertension: Focus on Intravenous Epoprostenol Eftychia DemeroutiPanagiotis KaryofyllisVassilios Voudris Leading Article 23 January 2019 Pages: 99 - 105
How Might Bromodomain and Extra-Terminal (BET) Inhibitors Operate in Cardiovascular Disease? C. Mary SchoolingJie V. Zhao Current Opinion 29 January 2019 Pages: 107 - 111
Tackling Residual Atherosclerotic Risk in Statin-Treated Adults: Focus on Emerging Drugs Kohei TakataStephen J. Nicholls Review Article 19 December 2018 Pages: 113 - 131
Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise Annabella Braschi Review Article 04 February 2019 Pages: 133 - 171
Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine Frédéric LapostolleArnoud W. van’t Hoffor the ATLANTIC Investigators Original Research Article 23 October 2018 Pages: 173 - 183
Optimal Medical Therapy Prescribing Patterns and Disparities Identified in Patients with Acute Coronary Syndromes at an Academic Medical Center in an Area with High Coronary Heart Disease-Related Mortality Ashley N. FoxGrant H. SkrepnekToni L. Ripley Original Research Article 10 November 2018 Pages: 185 - 193
Assessment of Non-vitamin K Oral Anticoagulants Use in a Tertiary Care Center in the USA: A Chart Review of 909 Patients Marwan Sheikh-TahaMary E. Deeb Original Research Article 08 November 2018 Pages: 195 - 201
Long-Term Effects of Bosentan on Cardiovascular Events in Hispanic Patients with Intermittent Claudication: Four-Year Follow-up of the CLAU Trial Joaquin De HaroSilvia BledaFrancisco Acin Original Research Article 12 November 2018 Pages: 203 - 209
Short-Term Effects of Tolvaptan in Tricuspid Insufficiency Combined with Left Heart Valve Replacement-Caused Volume-Overload Patients: Results of a Prospective Pilot Study Fang YuanZhangmin WuJunjie Zhang Original Research Article 25 September 2018 Pages: 211 - 218
Comment on: “Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials” Prashant B. RanaNilan T. JacobShraddha Bhure Letter to the editor 22 February 2019 Pages: 219 - 221
Authors’ Reply to Rana et al. “Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials” Usha K. MisraJayantee KalitaMethil Pradeep Letter to the editor 22 February 2019 Pages: 223 - 224
Correction to: Plasma Vitamin K1 Levels in Italian Patients Receiving Oral Anticoagulant Therapy for Mechanical Heart Prosthesis: A Case–Control Study Arturo CafollaAlessandra GentiliRoberta Curini Correction 09 February 2019 Pages: 225 - 225
Correction to: FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock Fortunato SenatoreGowraganahalli JagadeeshNorman Stockbridge Correction 01 March 2019 Pages: 227 - 227